Search

everythinglearnresearchcommunity

for

Search:↓

Some treatments can stabilize Frontal Fibrosing Alopecia, but more research is needed to find effective treatments, and hair transplants often fail.

New treatments for skin and hair disorders in women of color address unique biological differences and include specific acne medications, sunscreens, skin lighteners, and hair care adjustments.

PGA-4HGF may help treat hair loss by activating hair growth pathways and extending the hair growth phase.

Finding new uses for existing drugs is promising and can lead to safer, more effective medicines.

Customized medications made through compounding can be beneficial for various skin conditions but require careful regulation and collaboration between doctors and pharmacists.

Alopecia areata causes hair loss with varied treatment responses and frequent relapses.

Intralesional corticosteroids and 5-alpha-reductase inhibitors are the best treatments for frontal fibrosing alopecia.

The conclusion is that genetic testing is important for diagnosing and treating various genetic hair disorders.

The document concludes that changing the scalp's microbiome might be a new way to treat hair loss.

The document concludes that non-scarring alopecias can be reversed, but scarring alopecias cause permanent hair loss.

Accurate diagnosis of cicatricial alopecias requires thorough scalp examination and multiple biopsy techniques.

Five new mutations in the androgen receptor gene were found, helping to understand androgen insensitivity syndrome better.

Two new compounds were found to build bone and muscle without affecting reproductive organs and skin oil glands.

Certain interactions help prepare the androgen receptor for pairing and activation, which is important for its role in development and disease.

A 12-year-old boy with PAIS successfully developed male characteristics using high-dose testosterone and anastrozole.

Male children's genital development issues can be caused by genetic mutations or environmental factors affecting hormone action.

Mutations in the androgen receptor gene cause Androgen Insensitivity Syndrome, affecting sexual development.

Certain gene variations are linked to better memory in healthy Chinese women.

Longer CAG and GGN repeats increase alopecia risk, but no significant link to post-finasteride syndrome found.

Insufficient androgen action in male fetuses can cause genital development issues due to genetic mutations or environmental chemicals.

The girl's unexpected pubic hair growth led to a diagnosis different from complete androgen insensitivity syndrome.

Androgen treatment with dihydrotestosterone may help maintain height in patients with 5-α-reductase type 2 deficiency, especially before puberty.

A genetic test can identify people at risk of male pattern baldness early, allowing for quicker treatment.

Men with Kennedy disease have less chance of hair loss.

New genes and pathways are important for testosterone production and male sexual development.

The document suggests that targeting the hormone DHT could be a more effective treatment for prostate cancer than targeting testosterone.

Kennedy's disease leads to muscle weakness without a cure, but exercise and managing symptoms may help patients live a normal lifespan.

Current treatments for male pattern baldness include minoxidil and finasteride, with new options being developed.

Flutamide combined with an LHRH agonist effectively inhibits prostate growth, suggesting it could treat prostate cancer.

The normal human prostate does not significantly affect blood DHT levels.